A combination of factors, from oxytocin release as an indicator of emotional investment to cortisol and other hormones that correlate with attention, can forecast what people will do after an experience.
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
Comparing the brain scans of high-impact rugby players with those of athletes in noncontact sports, such as rowing and swimming, revealed tiny, yet significant, differences in the brain’s white matter.
Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.
After weeks of training, the muscles of two macaques exhibited greater responses to stimulation of the reticulospinal tract in the brain stem than they had before, suggesting that strengthening the neural pathway is key to getting stronger.